Light therapy for preventing seasonal affective disorder

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 11, 2015, Pages

  Nussbaumer, Barbara ^a   Kaminski Hartenthaler, Angela ^a   Forneris, Catherine A ^b   Morgan, Laura C ^c   Sonis, Jeffrey H ^b   Gaynes, Bradley N ^b   Greenblatt, Amy ^c   Wipplinger, Jörg ^a   Lux, Linda J ^c   Winkler, Dietmar ^d   Van Noord, Megan G ^a   Hofmann, Julia ^a   Gartlehner, Gerald ^a,c  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; ANTIDEPRESSANT AGENT; MELATONIN;

ADVERSE OUTCOME; BRIGHT LIGHT THERAPY; BRIGHT WHITE LIGHT THERAPY; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COMPARATIVE STUDY; DEPRESSION; DISEASE SEVERITY; HUMAN; INCIDENCE; INFRARED LIGHT THERAPY; INFRARED RADIATION; LIFESTYLE MODIFICATION; META ANALYSIS; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT SAFETY; PHOTOTHERAPY; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEASONAL AFFECTIVE DISORDER; SYSTEMATIC REVIEW; THERAPY EFFECT; ADULT; PROCEDURES;

ADULT; HUMANS; INCIDENCE; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEASONAL AFFECTIVE DISORDER;

EID: 84958215645     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011269.pub2     Document Type: Review

References (71)

1. Meesters Y, Beersma DG, Bouhuys AL, van den Hoofdakker RH. Prophylactic treatment of seasonal affective disorder (SAD) by using light visors: bright white or infrared light?. Biological Psychiatry 1999;46:239-46.
2. Graw P, Gisin B, Wirz-Justice A. Follow-up study of seasonal affective disorder in Switzerland. Psychopathology 1997;30:208-14.
3. Kasper S, Rogers SL, Yancey AL, Schulz PM, Skwerer RG, Rosenthal NE. Phototherapy in subsyndromal seasonal affective disorder (S-SAD) and "diagnosed" controls. Pharmacopsychiatry 1988;21:428-9.
4. Kjellman B, Lindwall/Sundel K, Stain/Malmgren R. The effect of prophylactic light therapy in SAD. Society Light Treatment Biological Rhythms 1997;9:24.
5. Lafer B, Sachs GS, Labbate LA, Thibault A, Rosenbaum JF. Phototherapy for seasonal affective disorder: a blind comparison of three different schedules. American Journal of Psychiatry 1994;151:1081-3.
6. Meesters Y, Lambers PA, Jansen JH, Bouhuys AL, Beersma DG, van den Hoofdakker RH. Can winter depression be prevented by light treatment?. Journal of Affective Disorders 1991;23:75-9.
7. Meesters Y, Jansen JH, Beersma DG, Bouhuys AL, van den Hoofdakker RH. Early light treatment can prevent an emerging winter depression from developing into a full-blown depression. Journal of Affective Disorders 1993;29:41-7.
8. Meesters Y, Jansen JH, Beersma DG, Bouhuys AL, van den Hoofdakker RH. An attempt to prevent winter depression by light exposure at the end of September. Biological Psychiatry 1994;35:284-6.
9. Meesters Y, Jansen JH, Beersma DG, Bouhuys AL, van den Hoofdakker RH. Light therapy for seasonal affective disorder. The effects of timing. British Journal of Psychiatry 1995;166:607-12.
10. Most Els IS, Scheltens P, Van Someren Eus JW. Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial. Trials 2010;11:11-9.
11. Norden MJ, Avery DH. Dawn simulation for subsyndromal winter depression. American Psychiatric Association. Abstracts. Paper No. 109A 2000.
12. Partonen T, Lonnqvist J. The influence of comorbid disorders and of continuation light treatment on remission and recurrence in winter depression. Psychopathology 1995;28:256-62.
13. Partonen T, Lonnqvist J. Prevention of winter seasonal affective disorder by bright-light treatment. Psychological Medicine 1996;26:1075-80.
14. Rohan KJ. Cognitive behavioral approaches to seasonal depression [NCT00076245]. ClinicalTrials.gov [www.clinicaltrials.gov] 2004.
15. Rohan KJ, Roecklein KA, Tierney Lindsey K, Johnson LG, Lippy RD, Lacy TJ, et al. A randomized controlled trial of cognitive-behavioral therapy, light therapy, and their combination for seasonal affective disorder. Journal of Consulting & Clinical Psychology 2007;75:489-500.
16. Rohan KJ, Roecklein KA, Lacy TJ, Vacek PM. Winter depression recurrence one year after cognitive-behavioral therapy, light therapy, or combination treatment. Behavioral Therapy 2009;40:225-38.
17. Rohan KJ, Evans M, Mahon JN, Sitnikov L, Ho S, Nillni YI, et al. Cognitive-behavioral therapy vs. light therapy for preventing winter depression recurrence: study protocol for a randomized controlled trial. Trials [electronic resource] 2013;14:82.
18. Terman JS, Terman M, Amira L. One-week light treatment of winter depression near its onset: the time course of relapse. Depression and Anxiety 1994;2:20-31.
19. Thorell LH, Kjellman B, Arned M, Lindwall-Sundel K, Walinder J, Wetterberg L. Light treatment of seasonal affective disorder in combination with citalopram or placebo with 1-year follow-up. International Clinical Psychopharmacology 1999;14 Suppl 2:S7-11.
20. University of Vermont, National Institute of Mental Health. Cognitive-Behavioral Therapy vs. Light Therapy for Preventing SAD Recurrence. clinicaltrials.gov 2014.
21. GlaxoSmithKline A 7-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of 150-300mg/day of Extended-Release Bupropion Hydrochloride (WELLBUTRIN XL) and Placebo for the Prevention of Seasonal Affective Disorder in Subjects with a History of Seasonal Affective Disorder Followed by an 8-Week Observational Follow-up Phase. GSK - Clinical Study Register [www.gsk-clinicalstudyregister.com] 2003.
22. Modell JG, Rosenthal NE, Harriett AE, Krishen A, Asgharian A, Foster VJ, et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biological Psychiatry 2005;58:658-67.
23. GlaxoSmithKline A 7-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of 150-300mg/day of Extended-Release Bupropion Hydrochloride (WELLBUTRIN XL) and Placebo for the Prevention of Seasonal Affective Disorder in Subjects with a History of Seasonal Affective Disorder Followed by an 8-Week Observational Follow-up Study. GSK - Clinical Study Register [www.gsk-clinicalstudyregister.com] 2004.
24. Modell JG, Rosenthal NE, Harriett AE, Krishen A, Asgharian A, Foster VJ, et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biological Psychiatry 2005;58:658-67.
25. GlaxoSmithKline A 7-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of 150-300mg/day of Extended-Release Bupropion Hydrochloride (WELLBUTRIN XL) and Placebo for the Prevention of Seasonal Affective Disorder in Subjects with a History of Seasonal Affective Disorder Followed by an 8-Week Observational Follow-up Phase. GSK - Clinical Study Register [www.gsk-clinicalstudyregister.com] 2003.
26. Modell JG, Rosenthal NE, Harriett AE, Krishen A, Asgharian A, Foster VJ, et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biological Psychiatry 2005;58:658-67.
27. Wirz-Justice A, Graw P, Krauchi K, Gisin B, Arendt J, Aldhous M, et al. Morning or night-time melatonin is ineffective in seasonal affective disorder. Journal of Psychiatric Research 1990;24:129-37.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. Washington, DC: American Psychiatric Association, 1980.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. Washington, DC: American Psychiatric Association, 1987.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: American Psychiatric Association, 2000.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. Washington, DC: American Psychiatric Association, 2013.
32. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
33. Berg TJ1, Spekreijse H. Near infrared light absorption in the human eye media. Vision Research 1997;37:249-53.
34. Byrne B, Brainard GC. Seasonal affective disorder and light therapy. Sleep Medicine Clinics 2008;3(2):307-15.
35. Ciarleglio CM, Resuehr HES, McMahon DG. Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues. Neuroscience 2011;197:8-16.
36. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629-34.
37. Forneris CA, Nussbaumer B, Kaminski-Hartenthaler A, Morgan LC, Gaynes BN, Sonis JH, et al. Psychological therapies for preventing seasonal affective disorder. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD011270]
38. Gartlehner G, Nussbaumer B, Gaynes BN, Forneris CA, Morgan LC, Kaminski-Hartenthaler A, et al. Second-generation antidepressants for preventing seasonal affective disorder. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD011268]
39. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. American Journal of Psychiatry 2005;162(4):656-62.
40. McMaster University and Evidence Prime Inc. GRADEpro Guideline Development Tool. McMaster University and Evidence Prime Inc, 2015.
41. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56-62.
42. Hansen RA, Moore CG, Dusetzina SB, Leinwand BI, Gartlehner G, Gaynes B. Controlling for drug dose in systematic review and meta-analysis: a case study of effect of antidepressant dose. Medical Decision Making 2009;29(1):91-103.
43. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
44. Joffe RT, Moul DE, Lam RW, Levitt AJ, Teicher MH, Lebeque B, et al. Light visor treatment for seasonal affective disorder: a multicenter study. Psychiatry Research 1993;46(1):29-39.
45. Kaminski-Hartenthaler A, Nussbaumer B, Forneris CA, Morgan LC, Gaynes BN, Sonis JH, et al. Melatonin and agomelatine for preventing seasonal affective disorder. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD011271]
46. Lam RW, Levitt AJ, eds Canadian Consensus Guidelines for the Treatment of Seasonal Affective Disorder. Clinical & Academic Publishing, 1999.
47. Lam RW, Levitt AJ, Levitan RD, Enns MW, Morehouse R, Michalak EE, et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry 2006;163(5):805-12.
48. Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychological Medicine 1999;29(4):869-78.
49. Levitan RD. What is the optimal implementation of bright light therapy for seasonal affective disorder (SAD)?. Journal of Psychiatry and Neuroscience 2005;30:72.
50. Levitan RD. The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues in Clinical Neuroscience 2007;9(3):315-24.
51. Lewy AJ, Sack RL, Miller LS, Hoban TM. Antidepressant and circadian phase-shifting effects of light. Science 1987;235:352-4.
52. Lewy AJ, Lefler BJ, Emens JS, Bauer VK. The circadian basis of winter depression. Proceedings of the National Academy of Sciences of the United States of America 2006;103:7414-9.
53. Magnusson A, Partonen T. The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectrums 2005;10(8):625-34.
54. Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak-Rieder N, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology 2011;64:152-62.
55. Partonen T, Lonnqvist J. Seasonal affective disorder. Lancet 1998;352:1369-74.
56. Quera-Salva MA, Hartley S, Barbot F, Alvarez JC, Lofaso F, Guilleminault C. Circadian rhythms, melatonin and depression. Current Pharmaceutical Design 2011;17:1459-70.
57. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
58. Rodin I, Thompson C. Seasonal affective disorder. Advances in Psychiatric Treatment 1997;3:352-9.
59. Rosen LN, Targum SD, Terman M, Bryant MJ, Hoffman H, Kasper SF. Prevalence of seasonal affective disorder at four latitudes. Psychiatry Research 1990;31:131-44.
60. Rosenthal R. The "file-drawer problem" and tolerance for null results. Psychological Bulletin 1979;86:638-41.
61. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry 1984;41(1):72-80.
62. Rosenthal NE, Moul DE, Hellekson CJ, Oren DA, Frank A, Brainard GC, et al. A multicenter study of the light visor for seasonal affective disorder: no difference in efficacy found between two different intensities. Neuropsychopharmacology 1993;8(2):151-60.
63. Schwartz PJ, Brown C, Wehr TA, Rosenthal NE. Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health Seasonal Studies Program. American Journal of Psychiatry 1996;153(8):1028-36.
64. Sohn CH, Lam RW. Update on the biology of seasonal affective disorder. CNS Spectrums 2005;10(8):635-46.
65. Teicher MH, Gold CA, Oren DA, Schwartz PJ, Luetke C, Brown C, Rosenthal NE. The phototherapy light visor: more to it than meets the eye. American Journal of Psychiatry 1995;152(8):1197-202.
66. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectrums 2005;10:647-63.
67. Thaler K, Delivuk M, Chapman A, Gaynes BN, Kaminski A, Gartlehner G. Second-generation antidepressants for seasonal affective disorder. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD008591.pub2]
68. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473-83.
69. Wells GA, Shea B, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Canadian Agency for Drugs and Technologies in Health (http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm) 2009.
70. Westrin A, Lam RW. Long-term and preventative treatment for seasonal affective disorder. CNS Drugs 2007;21(11):901-9.
71. Williams JBW, Link MJ, Rosenthal NE, Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale - Seasonal Affective Disorder version (SIGH-SAD). New York: New York State Psychiatric Institute, 2012.